Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03842033 · ClinicalTrials.gov registry record · NA

Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients

A NA study of Pediatric Asthma, sponsored by Arkansas Children's Hospital Research Institute.

Active
Registry status
NA
Development phase
370
Enrollment target
1
Study location

NCT03842033 is a NA study of Pediatric Asthma that is active but no longer recruiting, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 370 participants, below the 7,674-participant average among 9 other Pediatric Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03842033, a NA study of Pediatric Asthma, is active but no longer recruiting, sponsored by Arkansas Children's Hospital Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
370 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to test how good an app is in making asthma easier to manage for 372 adolescents/young adults. The app is a mobile version of the asthma action plan.

Conditions Studied

Interventions

  • BEHAVIORAL PEAKmAAP
  • BEHAVIORAL PEAKmAAP-DS
  • BEHAVIORAL NutriMap Usual Care

Study Locations (1)

Arkansas

  • Arkansas Children's Hospital Research Institute - Little Rock

Trial Details

FieldValue
Enrollment Target 370 participants
Start Date 2019-03-04
Est. Completion 2025-12-30
Phase NA

What the Registry Record Tells You About NCT03842033

The ClinicalTrials.gov registry entry for NCT03842033 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,674-participant average among 9 other Pediatric Asthma trials with a reported enrollment target (95% lower). The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric Asthma appearing as the primary indexed condition, and to 3 interventions - of which PEAKmAAP is the first listed.

NCT03842033 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT03842033 about?

NCT03842033 is a clinical study titled "Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients". The goal of this research study is to test how good an app is in making asthma easier to manage for 372 adolescents/young adults. The app is a mobile version of the asthma action plan.

What is the current status of trial NCT03842033?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 370 participants. The study started on 2019-03-04. Estimated completion is 2025-12-30.

What conditions does trial NCT03842033 study?

This clinical trial studies the following conditions: Pediatric Asthma.

What interventions are being tested in trial NCT03842033?

The interventions under investigation include: PEAKmAAP (BEHAVIORAL), PEAKmAAP-DS (BEHAVIORAL), NutriMap Usual Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03842033?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03842033 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.